RSS-Feed abonnieren
DOI: 10.4103/ajns.AJNS_372_20
Study of C677T methylene tetrahydrofolate reductase gene polymorphism as a risk factor for neural tube defects
Introduction: Various genetic and environmental factors contribute to the development of neural tube defects (NTDs) which are a group of neurulation defects resulting from failure of closure of embryonic neural tube. Among genetic factors is polymorphism in methylene tetrahydrofolate reductase (MTHFR) gene, giving rise to a gene variant or mutant. However, in most studies directed at finding an association between MTHFR variants and NTD, there is no clear evidence of a cause-and-effect relationship. Materials and Methods: Forty diagnosed cases of NTDs and forty healthy individuals were investigated in a case–control study for presence of C677T MTHFR gene polymorphism. Serum folate and Vitamin B12 levels were estimated and MTHFR gene polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism. Results: It was found that 32 cases were homozygous with CC genotype and eight were heterozygous with CT genotype, whereas 35 controls had CC genotype and five had CT genotype. TT genotype was absent in both the groups. There was no statistically significant difference between both the groups. No evidence of association between MTHFR C677T polymorphism and NTDs was found. Conclusion: Although there was no evidence of association between MTHFR C677T polymorphism and NTDs, our study does not rule out the impact of MTHFR gene mutation on folate metabolism. The reason for absence of TT genotype and no association could be a small sample size. Larger, comprehensive, and well-designed multicentric but feasible studies involving proper subjects and appropriate and adequate controls from several hospitals may provide more meaningful data.
Key-words:
Allele - association - methylene tetrahydrofolate reductase - neural tube defect - polymorphismFinancial support and sponsorship
Nil.
* contributed equally
Publikationsverlauf
Eingereicht: 29. Juli 2020
Angenommen: 26. März 2021
Artikel online veröffentlicht:
16. August 2022
© 2021. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Molloy AM, Pangilinan F, Brody LC. Genetic risk factors for folate-responsive neural tube defects. Annu Rev Nutr 2017;37:269-91.
- 2 National Center for Advancing Translational Sciences. MTHFR Gene Variant. National Institutes of Health; Bethesda, Maryland. Available from: https://rarediseases.info.nih.gov/diseases/10953/mthfr-gene-mutation. [Last accessed 2017 Sep 22].
- 3 van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1.
- 4 Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, et al. A genetic defect in 5, 10-methylenetetrahydrofolatereductase in neural tube defects. QJM 1995;88:763-6.
- 5 Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, et al. 5,10-Methylenetetrahydrofolatereductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996;63:610-4.
- 6 de Franchis R, Buoninconti A, Mandato C, Pepe A, Sperandeo MP, Del Gado R, et al. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for Spina Bifida in Italy. J Med Genet 1998;35:1009-13.
- 7 Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, et al. The “thermolabile” variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999;64:1045-55.
- 8 Behunova J, Klimcakova L, Zavadilikova E, Potocekova D, Sykora P, Podracka L. Methylenetetrahydrofolate reductase gene polymorphisms and neural tube defects epidemiology in the Slovak population. Birth Defects Res A Clin Mol Teratol 2010;88:695-700.
- 9 Félix TM, Leistner S, Giugliani R. Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 2004;70:459-63.
- 10 Perez AB, D'Almeida V, Vergani N, de Oliveira AC, de Lima FT, Brunoni D. Methylenetetrahydrofolate reductase (MTHFR): Incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet A 2003;119A: 20-5.
- 11 Sambrook J, Russell DW. Purification of nucleic acids by extraction with Phenol:Chloroform. CSH Protoc. 2006; pdb.prot 4455.
- 12 Micheal S, Qamar R, Akhtar F, Khan MI, Khan WA, Ahmed A. MTHFR gene C677T and A1298C polymorphisms and homocysteine levels in primary open angle and primary closed angle glaucoma. Mol Vis 2009;15:2268-78.
- 13 Al-Shahrani H, Al-Dabbagh N, Al-Dohayan N, Arfin M, Al-Asmari M, Rizvi S, et al. Association of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with primary glaucoma in Saudi population. BMC Ophthalmol 2016;16:156.
- 14 Shane B, Stokstad EL. Vitamin B12-folate interrelationships. Annu Rev Nutr 1985;5:115-41.
- 15 Godbole K, Deshmukh U, Yajnik C. Nutrigenetic determinants of neural tube defects in India. Indian Pediatr 2009;46:467-75.
- 16 Cadenas-Benitez NM, Yanes-Sosa F, Gonzalez-Meneses A, Cerrillos L, Acosta D, Praena-Fernandez JM, et al. Association of neural tube defects in children of mothers with MTHFR 677TT genotype and abnormal carbohydrate metabolism risk: A case-control study. Genet Mol Res 2014;13:2200-7.
- 17 van der Linden IJ, Afman LA, Heil SG, Blom HJ. Genetic variation in genes of folate metabolism and neural-tube defect risk. Proc Nutr Soc 2006;65:204-15.
- 18 Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, et al. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 2004;41:256-60.
- 19 Kirke PN, Mills JL, Molloy AM, Brody LC, O'Leary VB, Daly L, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: Case-control study. BMJ 2004;328:1535-6.
- 20 Mutchinick OM, López MA, Luna L, Waxman J, Babinsky VE. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: A country with a very high prevalence of neural tube defects. Mol Genet Metab 1999;68:461-7.
- 21 Muñoz JB, Lacasaña M, Cavazos RG, Borja-Aburto VH, Galavíz-Hernández C, Garduño CA. Methylenetetrahydrofolate reductase gene polymorphisms and the risk of anencephaly in Mexico. Mol Hum Reprod 2007;13:419-24.
- 22 Devi ARR, Govindaiah V, Ramakrishna G, Naushad SM. Prevalence of Methylene tetrahydrofolate reductase (MTHFR) gene polymorphism in South India. Current Science. 2004;86:440-3.
- 23 Cunha AL, Hirata MH, Kim CA, Guerra-Shinohara EM, Nonoyama K, Hirata RD. Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defects. Clin Chim Acta 2002;318:139-43.
- 24 Boduroğlu K, Alikaşifoğlu M, Anar B, Tunçbilek E. Association of the 677C-->T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects. J Child Neurol 1999;14:159-61.
- 25 Kondo A, Fukuda H, Matsuo T, Shinozaki K, Okai I. C677T mutation in methylenetetrahydrofolate reductase gene and neural tube defects: Should Japanese women undergo gene screening before pregnancy? Congenit Anom (Kyoto) 2014;54:30-4.
- 26 Fisk Green R, Byrne J, Crider KS, Gallagher M, Koontz D, Berry RJ. Folate-related gene variants in Irish families affected by neural tube defects. Front Genet 2013;4:223.
- 27 Naushad SM, Devi AR. Role of parental folate pathway single nucleotide polymorphisms in altering the susceptibility to neural tube defects in South India. J Perinat Med 2010;38:63-9.
- 28 Nauman N, Jalali S, Shami S, Rafiq S, Große G, Hilger AC, et al. Low maternal folate concentrations and maternal MTHFR C677T polymorphism are associated with an increased risk for neural tube defects in offspring: A case-control study among Pakistani case and control mothers. Asia Pac J Clin Nutr 2018;27:253-60.
- 29 Erdogan MO, Yildiz SH, Solak M, Eser O, Cosar E, Eser B, et al. C677T polymorphism of the methylenetetrahydrofolate reductase gene does not affect folic acid, vitamin B12, and homocysteine serum levels in Turkish children with neural tube defects. Genet Mol Res 2010;9:1197-203.
- 30 Barber R, Shalat S, Hendricks K, Joggerst B, Larsen R, Suarez L, et al. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas Hispanic population. Mol Genet Metab 2000;70:45-52.
- 31 Mornet E, Muller F, Lenvoisé-Furet A, Delezoide AL, Col JY, Simon-Bouy B, et al. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 1997;100:512-4.
- 32 Pardo R, Suazo J, Castillo S, Vargas M, Zalavari A, Santos JL, et al. Methylenetetrahydrofolate reductase polymorphisms as risk factors for myelomeningocele. Rev Med Chil 2014;142:587-92.
- 33 Nasri K, Midani F, Kallel A, Ben Jemaa N, Aloui M, Boulares M, et al. Association of MTHFR C677T, MTHFR A1298C, and MTRR A66G polymorphisms with neural tube defects in Tunisian parents. Pathobiology 2019;86:190-200.
- 34 Richter B, Stegmann K, Röper B, Böddeker I, Ngo ET, Koch MC. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J Hum Genet 2001;46:105-9.
- 35 Nishio K, Goto Y, Kondo T, Ito S, Ishida Y, Kawai S, et al. Serum folate and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism adjusted for folate intake. J Epidemiol 2008;18:125-31.
- 36 Deb R, Arora J, Meitei SY, Gupta S, Verma V, Saraswathy KN, et al. Folate supplementation, MTHFR gene polymorphism and neural tube defects: A community based case control study in North India. Metab Brain Dis 2011;26:241-6.
- 37 Hayati AR, Zainal AI, Tan GC, Ong LC, Khoo TB. MTHFR C677T polymorphism as a risk factor of neural tube defects in Malay: A case control study. Med J Malaysia 2008;63:379-83.
- 38 Sadewa AH, Sutomo R, Hayashi C, Lee MJ, Lee MJ, Ayaki H, et al. The C677T mutation in the methylene tetrahydrofolate reductase gene among the Indonesian Javanese population. Kobe J Med Sci 2002;48:137-44.
- 39 Dutta HK, Borbora D, Baruah M, Narain K. Evidence of gene-gene interactions between MTHFD1 and MTHFR in relation to anterior encephalocele susceptibility in Northeast India. Birth Defects Res 2017;109:432-44.
- 40 Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998;62:1258-60.
- 41 Volcik KA, Blanton SH, Tyerman GH, Jong ST, Rott EJ, Page TZ, et al. Methylenetetrahydrofolate reductase and spina bifida: Evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet 2000;95:21-7.
- 42 Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Cliver S, et al. Amniotic fluid homocysteine levels, 5, 10 methylene tetrahydrafolate reductase genotypes, and neural tube closure sites. Am J Med Genet 2000;90:6-11.
- 43 Botto LD, Yang Q. 5,10-Methylene tetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am J Epidemiol 2000;151:862-77.
- 44 Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7.